title: Possible implication of IKAROS gene deletion and BCR-ABL1 variants in progression of chronic myeloid leukemia to lymphoid blast crisis in childhood: a single-institution experience.
authors: a Hematology-Oncology Unit, First Department of Pediatrics , University of Athens, "Marianna V. Vardinoyiannis - ELPIDA", "Aghia Sofia" Children's Hospital , Athens , Greece.
authors: Maria
authors: M
authors: Moschovi
authors: a Hematology-Oncology Unit, First Department of Pediatrics , University of Athens, "Marianna V. Vardinoyiannis - ELPIDA", "Aghia Sofia" Children's Hospital , Athens , Greece.
authors: Maria
authors: M
authors: Adamaki
authors: a Hematology-Oncology Unit, First Department of Pediatrics , University of Athens, "Marianna V. Vardinoyiannis - ELPIDA", "Aghia Sofia" Children's Hospital , Athens , Greece.
authors: Anastasia
authors: A
authors: Athanasiadou
authors: b LIFE CODE Genetic Center for Research and Diagnosis , Athens , Greece.
authors: Aspasia
authors: A
authors: Divane
authors: b LIFE CODE Genetic Center for Research and Diagnosis , Athens , Greece.
authors: Anna
authors: A
authors: Karytianou
authors: a Hematology-Oncology Unit, First Department of Pediatrics , University of Athens, "Marianna V. Vardinoyiannis - ELPIDA", "Aghia Sofia" Children's Hospital , Athens , Greece.
authors: Natalia
authors: N
authors: Tourkantoni
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001752:Blast Crisis / Q000235:genetics* / Q000473:pathology; D002648:Child; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D017353:Gene Deletion; D014644:Genetic Variation; D006801:Humans; D051740:Ikaros Transcription Factor / Q000235:genetics*; D000068877:Imatinib Mesylate / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D051740:Ikaros Transcription Factor; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl